MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to agenus inc....
-$101K
Less net loss
attributable to...
-$3,198K
Revenue From Contract
With Customer...
$108,588K
Revenue From Contract
With Customer...
$4,238K
Revenue From Contract
With Customer...
$1,036K
Revenue From Contract
With Customer...
$334K
Net loss
-$3,083K
Gain from
deconsolidation of mink...
$100,924K
Dividends on series a-1
convertible preferred stock
$216K
Non Cash Royalty
Revenue
$108,588K
Pre Commercial
Product Revenue
$4,238K
Other
$1,036K
Clinical Product Revenue
$334K
Interest expense, net
-$55,273K
Mink therapeutics,
inc. equity method...
-$26,345K
Operating loss
-$20,169K
Non-operating income
(expense)
-$2,220K
Total revenues
$114,196K
Fair value
adjustments
$387K
Research and development
$79,338K
General and
administrative
$54,392K
Cost of revenue
$1,022K
Back
Back
Income Statement
source: myfinsight.com
AGENUS INC (AGEN)
AGENUS INC (AGEN)